OBND yields 6.34% · MRK yields 2.81%● Live data
📍 MRK pulled ahead of the other in Year 3
Combined, OBND + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of OBND + MRK for your $10,000?
The State Street Loomis Sayles Opportunistic Bond ETF (OBND) is an actively managed multi-asset credit strategy that seeks to capture risk premiums in markets it believes offer strong risk-adjusted return potential over a full market cycle due to Loomis Sayles' credit selection and risk management process The fund may invest in debt obligations of any credit quality across all fixed income sectors, including bank loans and securitized credit instruments, as well as allocate 100% of the portfolio into non-investment grade rated securitiesThe fund can also invest across the entire maturity curve with the duration of the portfolio (target duration between zero to seven years) managed based on the interest rate views of Loomis Sayles
Full OBND Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.